During the past decade, Thomas Jefferson Department of Neurosurgery conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Thomas Jefferson Department of Neurosurgery" are "Complex Regional Pain Syndrome (CRPS)" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Thomas Jefferson Department of Neurosurgery" in a lesser frequency.

Most popular intervention types in "Thomas Jefferson Department of Neurosurgery" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature" (1 trials), "Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature (virtual clinic and in-clinic sessions)" (1 trials), "Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System)" (1 trials) and "Dorsal Root Ganglion (DRG) Stimulation (Proclaim™ Neurostimulator System)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thomas Jefferson Department of Neurosurgery" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Thomas Jefferson Department of Neurosurgery". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Thomas Jefferson Department of Neurosurgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thomas Jefferson Department of Neurosurgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".